565 related articles for article (PubMed ID: 32584215)
1. Prospective multi-center evaluation on risk factors, clinical characteristics and outcomes due to carbapenem resistance in
Liu Y; Wang Q; Zhao C; Chen H; Li H; Wang H; Cares Network OBOT
J Med Microbiol; 2020 Jul; 69(7):949-959. PubMed ID: 32584215
[No Abstract] [Full Text] [Related]
2. Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.
Routsi C; Pratikaki M; Platsouka E; Sotiropoulou C; Nanas S; Markaki V; Vrettou C; Paniara O; Giamarellou H; Roussos C
Infection; 2010 Jun; 38(3):173-80. PubMed ID: 20224962
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
[TBL] [Abstract][Full Text] [Related]
4. [Risk factors and resistance patterns of invasive
Ge YL; Shan QW; Qiu Y; Zhou SP; Cheng YB; Wang F; Yang JW; Wan CM; Zhu Y; Xu Y; Chen MX; Lin DJ; Zhu CH; Zeng M
Zhonghua Er Ke Za Zhi; 2022 Aug; 60(8):762-768. PubMed ID: 35922185
[No Abstract] [Full Text] [Related]
5. Adaptations of carbapenem resistant
Sharma S; Das A; Banerjee T; Barman H; Yadav G; Kumar A
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33739918
[No Abstract] [Full Text] [Related]
6. Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia.
Zheng YL; Wan YF; Zhou LY; Ye ML; Liu S; Xu CQ; He YQ; Chen JH
Am J Infect Control; 2013 Jul; 41(7):e59-63. PubMed ID: 23523521
[TBL] [Abstract][Full Text] [Related]
7. Insights into the epidemiology, risk factors, and clinical outcomes of carbapenem-resistant
Zhang Y; Xu G; Miao F; Huang W; Wang H; Wang X
Front Public Health; 2023; 11():1282413. PubMed ID: 38098829
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Epidemiological Significance of Carbapenem Resistance in Acinetobacter baumannii Infections.
Tal-Jasper R; Katz DE; Amrami N; Ravid D; Avivi D; Zaidenstein R; Lazarovitch T; Dadon M; Kaye KS; Marchaim D
Antimicrob Agents Chemother; 2016 May; 60(5):3127-31. PubMed ID: 26883694
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for carbapenem-resistant Acinetobacter baumanii blood stream infections in a neonatal intensive care unit, Delhi, India.
Kumar A; Randhawa VS; Nirupam N; Rai Y; Saili A
J Infect Dev Ctries; 2014 Aug; 8(8):1049-54. PubMed ID: 25116673
[TBL] [Abstract][Full Text] [Related]
10. Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infections.
Esterly JS; Griffith M; Qi C; Malczynski M; Postelnick MJ; Scheetz MH
Antimicrob Agents Chemother; 2011 Oct; 55(10):4844-9. PubMed ID: 21825287
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of clinical characteristics and antimicrobial resistance of carbapenem-resistant Acinetobacter baumannii infections in children].
Zhang TQ; Dong L; Wang ZY; Li HY
Zhonghua Er Ke Za Zhi; 2011 Jul; 49(7):545-9. PubMed ID: 22088187
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study.
Jang TN; Lee SH; Huang CH; Lee CL; Chen WY
J Hosp Infect; 2009 Oct; 73(2):143-50. PubMed ID: 19716203
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for occurrence and 30-day mortality for carbapenem-resistant Acinetobacter baumannii bacteremia in an intensive care unit.
Kim SY; Jung JY; Kang YA; Lim JE; Kim EY; Lee SK; Park SC; Chung KS; Park BH; Kim YS; Kim SK; Chang J; Park MS
J Korean Med Sci; 2012 Aug; 27(8):939-47. PubMed ID: 22876063
[TBL] [Abstract][Full Text] [Related]
14. Mortality attributable to carbapenem-resistant nosocomial Acinetobacter baumannii infections in a Turkish university hospital.
Aydemir H; Celebi G; Piskin N; Oztoprak N; Keskin AS; Aktas E; Sumbuloglu V; Akduman D
Jpn J Infect Dis; 2012; 65(1):66-71. PubMed ID: 22274161
[TBL] [Abstract][Full Text] [Related]
15. Impact of antibiotic exposure on occurrence of nosocomial carbapenem-resistant Acinetobacter baumannii infection: a case control study.
Chusri S; Silpapojakul K; McNeil E; Singkhamanan K; Chongsuvivatwong V
J Infect Chemother; 2015 Feb; 21(2):90-5. PubMed ID: 25454216
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections.
Baran G; Erbay A; Bodur H; Ongürü P; Akinci E; Balaban N; Cevik MA
Int J Infect Dis; 2008 Jan; 12(1):16-21. PubMed ID: 17513154
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and outcomes of community and hospital-acquired Acinetobacter baumannii bacteremia.
Chusri S; Chongsuvivatwong V; Silpapojakul K; Singkhamanan K; Hortiwakul T; Charernmak B; Doi Y
J Microbiol Immunol Infect; 2019 Oct; 52(5):796-806. PubMed ID: 31031096
[TBL] [Abstract][Full Text] [Related]
18. Environmental colonization and onward clonal transmission of carbapenem-resistant
Ng DHL; Marimuthu K; Lee JJ; Khong WX; Ng OT; Zhang W; Poh BF; Rao P; Raj MDR; Ang B; De PP
Antimicrob Resist Infect Control; 2018; 7():51. PubMed ID: 29644052
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of bloodstream infections caused by Acinetobacter baumannii and impact of drug resistance to both carbapenems and ampicillin-sulbactam on clinical outcomes.
Chopra T; Marchaim D; Awali RA; Krishna A; Johnson P; Tansek R; Chaudary K; Lephart P; Slim J; Hothi J; Ahmed H; Pogue JM; Zhao JJ; Kaye KS
Antimicrob Agents Chemother; 2013 Dec; 57(12):6270-5. PubMed ID: 24100492
[TBL] [Abstract][Full Text] [Related]
20. A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia.
Nutman A; Glick R; Temkin E; Hoshen M; Edgar R; Braun T; Carmeli Y
Clin Microbiol Infect; 2014 Dec; 20(12):O1028-34. PubMed ID: 24930471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
